Want to join the conversation?
$MRK said it continues to work to achieve manufacturing readiness to supply the EU market, with product launches estimated to begin in 4Q16 or 1Q17. The U.S. FDA approved ZEPATIER 50mg/100mg tablets in January 2016 to treat adult patients with chronic HCV genotype 1 or 4 infection, with or without ribavirin (RBV).
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.